ALLMedicine™ Aphasia Center

Jun 29th, 2022 - Purpose: International health and social care policy increasingly draws on stakeholder experiences and opinions. The distinctions between various approaches to researching "insider" perspectives are contentious. This article explores features (e.g...

Jun 29th, 2022 - The ability to name pictures has been investigated widely in healthy people and clinical populations. The Object and Action Naming Battery (OANB) is widely used for psycholinguistic research, aphasia research, and clinical practice. Normative data...

Jun 25th, 2022 - A number of pharmaceuticals have been identified as potential adjuvants to speech language therapy following stroke, but it is also important to consider which pharmaceuticals may result in a less robust recovery. Here we examine whether post-stro...

Jun 23rd, 2022 - Focal anterior temporal lobe (ATL) degeneration often preferentially affects the left or right hemisphere. While patients with left-predominant ATL (lATL) atrophy show severe anomia and verbal semantic deficits and meet criteria for semantic varia...

Jun 22nd, 2022 - Practice Essentials Infective endocarditis (IE) is an infection of the endocardial surfaces of the heart—usually of 1 or more cardiac valves; to a lesser degree the mural endocardium, or a septal defect. IE may lead to severe valvular insufficienc...

Apr 9th, 2022 - Return to Work for People With Aphasia.|2022|Gilmore N,Fraas M,Hinckley J,|

Jun 22nd, 2022 - A. Evaluation Tasks Language Tasks: Participants will be administered baseline language and cognitive tasks, including 1 or more of the following, depending on their residual language and cognitive skills: a) writing to dictation b) oral spelling ...

Jun 22nd, 2022 - This proposal will extend the investigators' previous award, that provided the first evidence from a clinical trial (double-blind, sham-controlled, crossover), on the beneficial effects of transcranial direct current stimulation (tDCS) over the le...

Jun 21st, 2022 - Recent research has emphasized the need for intensive aphasia treatment in order to make the long-term neuroplastic changes associated with recovery and rehabilitation following a stroke. Furthermore, studies have indicated that intensive aphasia ...

Jun 21st, 2022 - tDCS Implementation: 2mA of direct current for 20 minutes will be delivered using a constant current stimulator via two electrodes in saline soaked sponges. To stimulate the left angular gyrus, a cathodal electrode inside a saline soaked sponge (5...

Jun 21st, 2022 - An acquired impairment in writing, also known as agraphia, is a characteristic symptom of aphasia, i.e., a language disorder resulting from damage to the language centers of the brain. Written communication via text and instant messaging, electron...

Jun 22nd, 2022 - It's well understood that physicians have limited time to treat patients with stroke before the disease progresses and outcomes can worsen. This case illustrates how differing opinions by remote and in-person physicians — followed by system breakd...

Jun 14th, 2022 - On the basis of the patient's presentation, family history, and personal history of headache, she seems to be presenting with hemiplegic migraine, an uncommon migraine subtype characterized by recurrent headaches associated with temporary unilater.

Jun 2nd, 2022 - The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways High tCr and low glutamate+glutamine (Glx) metabolite levels in the left inferior frontal gyrus (IFG) correlate with gre...

May 12th, 2022 - In patients with "wake-up" stroke selected by noncontrast CT, treatment with tenecteplase did not significantly improve functional outcome at 90 days in the TWIST trial. Although tenecteplase treatment was associated with a higher proportion of pa...

Apr 28th, 2022 - The FDA has approved axicabtagene ciloleucel (axi-cel; Yescarta) for the treatment of adult patients with large B-cell lymphoma that is refractory to first-line chemoimmunotherapy or relapses within 12 months of first-line chemoimmunotherapy.1 Th...